Atopic Dermatitis: Older Adjuncts Worth Remembering

Atopic dermatitis is rarely a one-product problem. It is a chronic inflammatory disease shaped by barrier dysfunction, itch, microbial factors, triggers, and the practical realities of daily skin care. While current topical, systemic, and biologic options have changed the treatment landscape, many patients still need additional ways to support the barrier, reduce itch, and improve adherence.

That is where a few older, or at least less frequently discussed, approaches can be useful. I do not view these as replacements for evidence-based eczema treatment. Rather, they are potential adjuncts for selected patients when they are safe, practical, and consistent with the patient’s overall treatment plan.

Quick answer: Older approaches such as barrier-supportive oils, coal tar, topical vitamin B12, and other itch-focused options may be useful as adjuncts for selected patients. They do not replace a confirmed diagnosis, foundational skin care, or an appropriate anti-inflammatory treatment plan.

Can Oils Support the Skin Barrier?

The first principle in atopic dermatitis remains barrier support. Older studies have explored topical oils for their ability to improve hydration and replenish lipids within the stratum corneum. Sunflower seed oil, for example, has been associated with improved barrier integrity and skin hydration. Evening primrose oil cream and borage-oil-containing garments have also shown symptom improvement in limited studies.

The key is to avoid treating “natural” as synonymous with “gentle.” Any oil or botanical can be irritating or allergenic, especially on actively inflamed, fissured, or infected skin. I favor simple, fragrance-free, well-tolerated barrier products first, while recognizing that certain oil-based approaches may be reasonable for carefully selected patients.

Does Coal Tar Still Have a Place in Atopic Dermatitis Care?

Coal tar is one of the oldest treatments in dermatology, and it remains a useful reminder that age does not equal obsolescence. It has anti-inflammatory effects and may support barrier repair, including pathways relevant to filaggrin expression. Its limitations are familiar: odor, staining, messiness, and patient acceptance.

For the right patient, however, especially someone with chronic lichenified disease who is looking for a steroid-sparing adjunct, tar-based therapy may be worth discussing. Product selection, body site, tolerability, and patient preferences matter enormously.

What Do We Know About Vitamin B12, Caffeine, and Itch?

Topical vitamin B12 has been studied in atopic dermatitis and may offer an anti-inflammatory effect through modulation of proinflammatory cytokines. Similarly, an older study suggested that caffeine used with low-potency hydrocortisone improved lichenification and excoriation more than hydrocortisone alone.

These findings are interesting, but they do not place either ingredient on the same level as standard anti-inflammatory therapies. I think of them as examples of how familiar compounds may have a role in future vehicle design or adjunctive products, rather than as universal recommendations.

What About Vitamin D, Probiotics, and Cannabinoid-Related Compounds?

The literature also raises questions about vitamin D, probiotics, and cannabinoid-related compounds. Vitamin D levels have been associated with atopic dermatitis severity in some studies, and small trials have suggested potential benefit in selected seasonal or pediatric patterns. Probiotics may influence immune signaling, but outcomes are strain-specific and inconsistent enough that broad recommendations remain premature.

Cannabinoid-related compounds, including palmitoylethanolamide, are particularly interesting for itch, inflammation, and barrier recovery. The challenge is that commercially available products vary widely in formulation, quality, and evidence. Patients deserve honest counseling: “promising” is not the same as “proven.”

How I Evaluate Adjunctive Eczema Treatments

When patients ask about older or adjunctive eczema remedies, I return to a practical framework:

• Confirm the diagnosis and look for complicating infection, contact dermatitis, or poor treatment fit.
• Build the foundation first: gentle cleansing, adequate moisturization, trigger reduction, and an appropriate anti-inflammatory plan.
• Consider adjuncts only when their potential benefit outweighs the risks of irritation, allergy, cost, or treatment delay.
• Reassess objectively. If a treatment is not helping, it should not remain in the routine simply because it is “natural” or familiar.

The most valuable lesson from these historical treatments is not that every old remedy deserves a revival. It is that atopic dermatitis care should remain individualized, barrier-focused, and open to safe, evidence-informed adjuncts.

If you are experiencing persistent, recurring, or difficult-to-control eczema symptoms, contact RM Dermatology to schedule an individualized evaluation.